Skip to content

Based on the function of the brain-gut axis the clinical efficacy of Shenque patching of traditional Chinese medicine in the treatment of drug-related constipation in female detoxification after detoxification was explored

Based on the function of the brain-gut axis the clinical efficacy of Shenque patching of traditional Chinese medicine in the treatment of drug-related constipation in female detoxification after detoxification was explored

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001750
Enrollment
Unknown
Registered
2025-09-15
Start date
2024-06-14
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Interventions

treatment:Acupuncture point application
control :Oral lactulose

Sponsors

DongNan Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Female detoxification after detoxification between the ages of 20 and 60 years; 2. Patients who self-reported unsatisfactory intestinal clearance and who met Rome-III diagnostic criteria for functional constipation were included in this study. According to the Rome-III diagnostic method for functional constipation subjects have at least two of the following symptoms at the most recent three-month screening visit: (1) straining to defecate >25%; (2) >25% of bowel movements were lumpy or hard; (3) >25% of bowel movements felt incomplete bowel movements; (4) >25% of bowel movements had a sensation of anorectal obstruction/obstruction; (5) manual manipulation of >25% of bowel movements; (6) Less than 3 bowel movements per week . Subject voluntarily participates in the study and complies with the trial procedures by signing a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of gastrointestinal disorders (e.g. irritable bowel disease Crohn's disease celiac disease) or severe gastrointestinal complications requiring medical intervention. 2. Women who have recently tried to get pregnant or are pregnant or breastfeeding. 3. Patients with abdominal trauma umbilical skin rupture and surgical history. 4. Patients with systemic diseases such as severe diabetes tuberculosis connective tissue diseases and immune system diseases. 5. Other patients who may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Overall relief rate;

Secondary

MeasureTime frame
Quality of Life Assessment;Clinical biochemical assessment;

Countries

China

Contacts

Public ContactZhiMing Han

DongNan Hospital of Chongqing

cqzyylxz99@126.com17823347080

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026